TY - JOUR
T1 - Advancing Stroke Recovery Through Improved Articulation of Nonpharmacological Intervention Dose
AU - Hayward, Kathryn S
AU - Churilov, Leonid
AU - Dalton, Emily J
AU - Brodtmann, Amy
AU - Campbell, Bruce C V
AU - Copland, David
AU - Dancause, Numa
AU - Godecke, Erin
AU - Hoffmann, Tammy C
AU - Lannin, Natasha A
AU - McDonald, Matthew W
AU - Corbett, Dale
AU - Bernhardt, Julie
N1 - Funding Information:
Person: National Health and Medical Research Council (NHMRC): Dr Hayward, No. 1088449; Dr Bernhardt, No. 1154904; Dr Campbell, No. 1174514. National Heart Foundation of Australia: Dr Lannin, FLF102055; Dr Brodt-mann, FLF100784. Fonds de Recherche du Québec-Santé (389886): Dr Dancause. Research Training Program Scholarship: E.J. Dalton. Canadian Vascular Network: Dr McDonald. Project: NHMRC Centre of Research Excellence in Stroke Rehabilitation and Brain Recovery: Dr Bernhardt/Dr Churilov (No. 1077898). NHMRC Centre of Research Excellence in Aphasia Recovery and Rehabilitation: Dr Copland/Dr Godecke/Dr Bernhardt/Dr Churilov. NHMRC grant (No. 1044973): Dr Godecke. Canadian Institutes of Health Research grant (No. 389886): Dr Dancause. Canadian Partnership for Stroke Recovery grant: Dr Hayward/Dr Corbett/Dr McDonald/Dr Churilov/E.J. Dalton.
Funding Information:
The Florey Institute of Neuroscience and Mental Health acknowledges strong support from the Victorian Government, in particular, funding the Operational Infrastructure Support Grant. We thank all members of the international expert advisory group.
Publisher Copyright:
© 2021 American Heart Association, Inc.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Dose articulation is a universal issue of intervention development and testing. In stroke recovery, dose of a nonpharmaceutical intervention appears to influence outcome but is often poorly reported. The challenges of articulating dose in nonpharmacological stroke recovery research include: (1) the absence of specific internationally agreed dose reporting guidelines; (2) inadequate conceptualization of dose, which is multidimensional; and (3) unclear and inconsistent terminology that incorporates the multiple dose dimensions. To address these challenges, we need a well-conceptualized and consistent approach to dose articulation that can be applied across stroke recovery domains to stimulate critical thinking about dose during intervention development, as well as promote reporting of planned intervention dose versus actually delivered dose. We followed the Design Research Paradigm to develop a framework that guides how to articulate dose, conceptualizes the multidimensional nature and systemic linkages between dose dimensions, and provides reference terminology for the field. Our framework recognizes that dose is multidimensional and comprised of a duration of days that contain individual sessions and episodes that can be active (time on task) or inactive (time off task), and each individual episode can be made up of information about length, intensity, and difficulty. Clinical utility of this framework was demonstrated via hypothetical application to preclinical and clinical domains of stroke recovery. The suitability of the framework to address dose articulation challenges was confirmed with an international expert advisory group. This novel framework provides a pathway for better articulation of nonpharmacological dose that will enable transparent and accurate description, implementation, monitoring, and reporting, in stroke recovery research.
AB - Dose articulation is a universal issue of intervention development and testing. In stroke recovery, dose of a nonpharmaceutical intervention appears to influence outcome but is often poorly reported. The challenges of articulating dose in nonpharmacological stroke recovery research include: (1) the absence of specific internationally agreed dose reporting guidelines; (2) inadequate conceptualization of dose, which is multidimensional; and (3) unclear and inconsistent terminology that incorporates the multiple dose dimensions. To address these challenges, we need a well-conceptualized and consistent approach to dose articulation that can be applied across stroke recovery domains to stimulate critical thinking about dose during intervention development, as well as promote reporting of planned intervention dose versus actually delivered dose. We followed the Design Research Paradigm to develop a framework that guides how to articulate dose, conceptualizes the multidimensional nature and systemic linkages between dose dimensions, and provides reference terminology for the field. Our framework recognizes that dose is multidimensional and comprised of a duration of days that contain individual sessions and episodes that can be active (time on task) or inactive (time off task), and each individual episode can be made up of information about length, intensity, and difficulty. Clinical utility of this framework was demonstrated via hypothetical application to preclinical and clinical domains of stroke recovery. The suitability of the framework to address dose articulation challenges was confirmed with an international expert advisory group. This novel framework provides a pathway for better articulation of nonpharmacological dose that will enable transparent and accurate description, implementation, monitoring, and reporting, in stroke recovery research.
UR - http://www.scopus.com/inward/record.url?scp=85100445740&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.120.032496
DO - 10.1161/STROKEAHA.120.032496
M3 - Comment/debate/opinion
C2 - 33430635
SN - 0039-2499
VL - 52
SP - 761
EP - 769
JO - Stroke
JF - Stroke
IS - 2
ER -